If your protocol calls for 200 mcg of CJC-1295 and 200 mcg of Ipamorelin per dose (a 1:1 blend), the combined target is 400 mcg
Santini G, Mores N, Shohreh R, Valente S, Dabrowska M, Trove A, et al
Sugar reduction for balanced energy and taste adaptation GLP-1 medications can alter taste preferences, making patients more sensitive to sweetness and decreasing preference for high-fat, non-sweet foods during the weight loss phase
In addition, MSCs may exert an inhibitory effect on EMT by regulating core transcription factors such as Snail and Twist1
Compounded medications may be prescribed when a licensed provider determines they are appropriate for an individual patient